Brief History of Permanent Cardiac Pacing
Article Sidebar
Main Article Content
Abstract
A permanent cardiac pacemaker is an implantable device used to maintain a sufficient heart rate when the natural mechanisms fail, either as a result of a deficiency with the natural pacemaker or the conduction system in the heart.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
PE Vardas, A Auricchio, JJ Blanc, JC Daubert, H Drexler, H Ector, M Gasparini, C Linde, FB Morgado, A Oto, R Sutton, M Trusz-Gluza. European Society of Cardiology; European Heart Rhythm Association
Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association
Europace. 2007;10:959-998
FM Kusumoto, N Goldschlager
Cardiac Pacing
N Engl J Med 1996;334:89-97
K Jeffrey, V Parsonnet
Cardiac Pacing 1960-1985: a quarter century of medical and industrial innovation.
Circulation 1998;97:1978-1991
RG Trohman, MH Kim, SL Pinski
Cardiac Pacing: the state of art
Lancet 2004;364:1701-1719
B Luderitz
We have come a long way with device therapy: historical perspective on antiarrhythmic electrotherapy
J Cardiovasc Electrophysiol 2002; 13 (Suppl. 1):S2-S8
D Zipes, J Jalife
Cardiac Electrophysiology: from cell to bedside (Third Edition)
Chapter 107 page 974
S Furman, JB Schwedel
An Intracardiac pacemaker for Stokes-Adams seizure
N Engl J Med 1959;261:943-948
V Personnet, S Furman, NPD Smith
Implantable cardiac pace-makers status report and resource guideline. Pace-maker study group
Circulation 1974; 50:A21-A35
D Bernstein, AJ Camm, RD Fletcher RD Gold, AF Rickards, NP Smyth, SR Spielman, R Sutton
The NASPE/BPEG generic pace-makers code for anti-bradiarrhythmic and adaptive-rate pacing and anti-tachyarrhythmia devices
Pacing and Clin Electrophysiol 1987;10:794-499
G Gregoratos, MD Cheitlin, A Conill, AE Epstein,C Fellows, TB Jr Ferguson, RA Freedman, MA Hlatky, GV Naccarelli, S Saksena, RC Schlant, MJ Silka, JL Ritchie, RJ Gibbons, KA Eagle, TJ Gardner, RP Lewis, RA O'Rourke, TJ Ryan, A Jr Garson.
ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines
J Am Coll Cardiol 1998;31(5):1175-209
EJ Perrins, R Sutton, B Kalebic, LR Richards, C Morley, B Terpstra
Modern Atrial and Ventricular Leads for Permanent Cardiac Pacing
Br Heart J 1981;46:196-201
M Kleinert, M Bock, L Wilhelmi
Clinical use of a new transvenous atrial lead
Am J Cardiol 1977;40:237-242
IB Kruse, L Ryden, B Ydse
Clinical and Electrophysiological characteristics of a transvenous atrial lead
Br Heart J 1079;42:595-602
JS Geddes, SW Webb, IP Clements
Clinical Experience with a new transvenous atrial pacing
Br Heart J 1978;40:589-595
HJ Bisping, J Kreuzer, H Birkenheier
Three Years clinical experience with a new endocardial screw-in lead with introduction protection for use in atrium and ventricle
Pacing and Clin Electrophysiol 1980;3:424-435
SJ Bailin
Atrial lead implantation in the Bachmann bundle.
Heart Rhythm 2005;7:784-786
L Padeletti, P Pieragnoli, C Ciapetti, A Colella, N Musilli, MC Porciani, R Ricci, C Pignalberi, M Santini, A Puglisi, P Azzolini, A Spampinato, M Martelli, A Capucci, G Boriani, G Botto, A Proclemer
Randomized Crossover Comparison of Right Atrial Appendage Pacing versus Interatrial Spetum Pacing for Prevention of Paroxysmal Atrial Fibrillation in Patients with sinus Bradycardia
AM Heart J 2001;142:1047-1055
ARJ Mitchel, N Sulke,
How do atrial pacing algorithms prevent atrial arrhythmias?
Europace 2004;6:351362
S Cazeau, C Leclercq, T Lavergne, S Walker, C Varma, C Linde, S Garrigue, L Kappenberger, GA Haywood, M Santini, C Bailleul, JC Daubert
Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators.
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
N Engl J Med 2001;12:873-880
MG Sutton T Plappert, WT Abraham, AL Smith, DB DeLurgio, AR Leon, E Loh, DZ Kocovic,WG Fisher, M Ellestad, J Messenger, K Kruger, KE Hilpisch, MR Hill. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group.
Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
Circulation 2003;15:1985-1990
J Han, D Millet, B Chizzonitti, GK Moe
Temporal Dispersion of Recovery of Excitability in Atrium and Ventricle as a function of Heart Rate
Am Heart J 1966;71:481-487